Skip to content

Comparison of sedative effects of remiazolam and music intervention on patients undergoing transurethral resection of prostate under spinal anesthesia: a prospective randomized controlled study

Comparison of sedative effects of remiazolam and music intervention on patients undergoing transurethral resection of prostate under spinal anesthesia: a prospective randomized controlled study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071284
Enrollment
Unknown
Registered
2023-05-10
Start date
2023-05-22
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostatic hyperplasia

Interventions

control group:Music intervention
experimental group 1:Remidazolam
experimental group 2:Remidazolam combined with music
blank group:None

Sponsors

Liaoning Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing electroprostatectomy for the first time under elective intraspinal anesthesia; 2. Aged 60-80 years; 3. Body mass index (BMI) 18.5-30kg/m^2; 4. ASA grade I-III; 5. Voluntary signing of informed consent.

Exclusion criteria

Exclusion criteria: 1. People with hearing and visual impairment; 2. People with intravertebral anesthesia contraindications; 3. Severe hypertension (still above level 3 after taking medication), cardiac insufficiency (NYHA> Level II); 4. People with severe bradycardia (installation of pacemakers); 5. People with neuromuscular system diseases and mental diseases; 6. History of sedative drugs, antidepressants, alcohol and drug abuse; 7. Complications after a history of severe cerebrovascular disease or craniocerebral trauma (such as emotional disorders, impaired speech, etc.); 8. People who are known to be allergic to benzodiazepines; 9. Uncooperative or unable to communicate.

Design outcomes

Primary

MeasureTime frame
Bispectral index;

Secondary

MeasureTime frame
Age;Weight;Height;Body mass index;ASA classification;Systolic pressure;Diastolic pressure;Mean arterial pressure;Heart rate;Oxygen saturation;Total dosage of remidazolam;Departure time;Awakening time;Satisfaction;Cognitive function;Anxiety;Hypoxemia;Nausea;Vomit;Respiratory depression;Operation duration;Puncture space;Dosage of ropivacaine;

Countries

China

Contacts

Public ContactWang Changming

Liaoning Provincial People's Hospital

TeamWangCM@163.com+86 177 0248 6100

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026